Parenteral Drugs (India) reports standalone net loss of Rs 17.49 crore in the March 2015 quarter

Sales decline 10.70% to Rs 36.15 crore

Net Loss of Parenteral Drugs (India) reported to Rs 17.49 crore in the quarter ended March 2015 as against net loss of Rs 9.28 crore during the previous quarter ended March 2014. Sales declined 10.70% to Rs 36.15 crore in the quarter ended March 2015 as against Rs 40.48 crore during the previous quarter ended March 2014.

For the full year,net loss reported to Rs 54.08 crore in the year ended March 2015 as against net loss of Rs 58.70 crore during the previous year ended March 2014. Sales declined 5.69% to Rs 175.89 crore in the year ended March 2015 as against Rs 186.51 crore during the previous year ended March 2014.

ParticularsQuarter EndedYear EndedMar. 2015Mar. 2014% Var.Mar. 2015Mar. 2014% Var.Sales36.1540.48 -11 175.89186.51 -6 OPM %12.92-55.39 -7.62-8.94 - PBDT-10.83-36.40 70 -45.76-70.92 35 PBT-21.42-40.95 48 -69.61-88.62 21 NP-17.49-9.28 -88 -54.08-58.70 8

Powered by Capital Market - Live News